Tonix Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. 

CEO
Seth Lederman
CEOSeth Lederman
Employees
142
Employees142
Headquarters
Berkeley Heights, New Jersey
HeadquartersBerkeley Heights, New Jersey
Founded
2007
Founded2007
Employees
142
Employees142

TNXP Key Statistics

Market cap
169.28M
Market cap169.28M
Price-Earnings ratio
-0.76
Price-Earnings ratio-0.76
Dividend yield
—
Dividend yield—
Average volume
523.41K
Average volume523.41K
High today
$9.99
High today$9.99
Low today
$9.62
Low today$9.62
Open price
$9.78
Open price$9.78
Volume
380.46K
Volume380.46K
52 Week high
$25.52
52 Week high$25.52
52 Week low
$9.40
52 Week low$9.40

Stock Snapshot

Tonix Pharmaceuticals(TNXP) stock is priced at $9.90, giving the company a market capitalization of 169.28M. It carries a P/E multiple of -0.76.

During the trading session on 2026-09-26, Tonix Pharmaceuticals(TNXP) shares reached a daily high of $9.99 and a low of $9.62. At a current price of $9.90, the stock is +2.9% higher than the low and still -0.9% under the high.

Trading volume for Tonix Pharmaceuticals(TNXP) stock has reached 380.46K, versus its average volume of 523.41K.

The stock's 52-week range extends from a low of $9.40 to a high of $25.52.

The stock's 52-week range extends from a low of $9.40 to a high of $25.52.

TNXP News

TipRanks 5d
Tonix Pharma expands TONMYA Medicare Part D coverage

The latest update is out from Tonix Pharma ( (TNXP) ). On September 22, 2026, Tonix Pharmaceuticals announced it had entered into an agreement with a pharmacy...

TipRanks 5d
Tonix announces second major managed Medicare payer agreement for TONMYA

Tonix Pharmaceuticals (TNXP) announced a second major managed Medicare agreement for TONMYA for the treatment of fibromyalgia in adults that is effective immedi...

Investing.com 5d
Raymond James reiterates Strong Buy on Tonix Pharma stock at $27 - Investing.com

...

Raymond James reiterates Strong Buy on Tonix Pharma stock at $27 - Investing.com

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.